SCHEMBL19933658

SCHEMBL19933658

c1ccc(-c2cc(-c3ccccc3-c3ccc(-c4ccc5oc6ccccc6c5c4)nc3)cc(-c3ccccc3-c3ccc(-c4ccc5oc6ccccc6c5c4)nc3)c2)c(-c2ccc(-c3cnc(-c4ccc(-c5ccccc5-c5cc(-c6ccccc6-c6ccc(-c7ccc8oc9ccccc9c8c7)nc6)cc(-c6ccccc6-c6ccc(-c7ccc8oc9ccccc9c8c7)nc6)c5)cc4)cn3)cc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
NPC1 O15118 2/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ALOX5 P09917 1/20 0.36
FEN1 P39748 4/20 0.36
LMNA P02545 1/20 0.36
CASP3 P42574 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
CHEK2 O96017 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HSD17B1 P14061 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18015535 0.95 HSP90AA1 (0.43) HSP90AA1HSP90AB1NPC1MAPTKDM4E
SCHEMBL21662179 0.94 HDAC6 (0.41) HSP90AA1HSP90AB1NPC1MAPTKDM4E
SCHEMBL19933652 0.89 AHR (0.40) HSP90AA1HSP90AB1NPC1MAPTKDM4E
SCHEMBL19794373 0.87 AHR (0.41) NPC1MAPTKDM4EMEN1ALDH1A1
SCHEMBL19794433 0.86 HSD17B1 (0.39) MAPTKDM4EMEN1ALDH1A1HPGD
SCHEMBL21662180 0.85 NPC1 (0.38) HSP90AA1HSP90AB1NPC1MAPTKDM4E
SCHEMBL19933761 0.83 HSP90AA1 (0.40) HSP90AA1HSP90AB1NPC1MAPTKDM4E
SCHEMBL19794443 0.83 CYP11B1 (0.38) HDAC6HSD17B1HSD17B2DYRK1A
SCHEMBL21398039 0.83 HSD17B1 (0.36) HSP90AA1HSP90AB1NPC1MAPTKDM4E
SCHEMBL18015576 0.81 CYP11B1 (0.39) HDAC6HSD17B1HSD17B2GRM4DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3507294-B1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-02-24 EP disclosed
US-10889604-B2 Binuclear and trinuclear metal complexes composed of two inter-linked tripodal hexadentate ligands for use in electroluminescent devices MERCK PATENT GMBH 2021-01-12 US disclosed
US-20190202851-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2019-07-04 US disclosed
WO-2018041769-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190202851-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES PARN, PUF60, PARG HSP90AA1 4714/4885HSP90AB1 4815/4885NPC1 4603/4885
US-10889604-B2 Binuclear and trinuclear metal complexes composed of two inter-linked tripodal hexadentate ligands for use in electroluminescent devices PARN, PUF60, PARG HSP90AA1 4714/4885HSP90AB1 4815/4885NPC1 4603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.